The management team are on their game and things are progressing...

  1. 244 Posts.
    lightbulb Created with Sketch. 38
    The management team are on their game and things are progressing well with data flow this quarter and likely FDA approval 2020. This is relatively de-risked as a bio stock given that have a product that is known to work with increasing revenue generation and further studies in the pipeline around nerve injury and tendon repair. This should see the SP head north during Q3. The next 6 months will be exciting
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.24
Change
-0.025(1.98%)
Mkt cap ! $303.5M
Open High Low Value Volume
$1.27 $1.27 $1.23 $333.2K 267.3K

Buyers (Bids)

No. Vol. Price($)
1 8397 $1.24
 

Sellers (Offers)

Price($) Vol. No.
$1.26 10305 2
View Market Depth
Last trade - 16.10pm 14/07/2025 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.